VESIcare Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
Condition:   Overactive Bladder (OAB) Interventions:   Drug: mirabegron;   Device: solifenacin;   Drug: darifenacin;   Drug: imidafenacin;   Drug: tolterodine;   Drug: oxybutynin;   Drug: trospium;   Drug: fesoterodine;   Device: propiverine Sponsor:   Astellas Pharma Singapore Pte. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2018 Category: Research Source Type: clinical trials